Alternatives may include patient assistance programs, different medications, or adjusted treatment plans
It is also approved for chronic weight management in adults who are obese (BMI 30) or overweight (BMI 27) and have at least one weight-related comorbid condition, such as hypertension or dyslipidemia
Anyone weighing GLP-1-pathway options should discuss FDA-approved, provider-supervised therapies with a qualified healthcare provider rather than acting on trial figures or on anything bought outside the regulated system
Some compounded formulations include additional ingredients
While the reaction is new to Ozempic packaging, gastrointestinal side effects are common for GLP-1 medicines
In preclinical models, GLP-1 receptor agonists appear to modulate inflammatory signalling pathways such as nuclear factor kappa B (NF-B), a key transcription factor regulating inflammatory gene expression